Resmed unveils 2030 strategy to drive growth, profitability, and shareholder returns

New york and san diego, sept. 30, 2024 (globe newswire) -- resmed (nyse: rmd, asx: rmd) today unveiled its 2030 strategy to drive growth, profitability, and shareholder returns at an investor day in new york city. resmed also announced its five-year revenue and earnings growth outlook, reflecting resmed's plans to accelerate product and technology innovation, operational excellence, commercial execution, and financial strength. driven by the new strategy, resmed expects to help more than 500 million people worldwide achieve their full health potential in 2030.
RMD Ratings Summary
RMD Quant Ranking